Rare neurological condition is ‘important potential risk’ of Pfizer’s RSV vaccine, FDA says [W[R]C]
25 feb 2023 ·
7 min. 30 sec.
![Rare neurological condition is ‘important potential risk’ of Pfizer’s RSV vaccine, FDA says [W[R]C]](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/91caa85ea30b55b466e6524f19d0f2ad.jpg)
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Capitoli
Descrizione
https://www.cnn.com/2023/02/24/health/pfizer-rsv-vaccine-guillain-barre/index.html CNN — Two people who received Pfizer’s respiratory syncytial virus (RSV) vaccine during a clinical trial were later diagnosed with Guillain-Barre syndrome, and the US Food and Drug Administration...
mostra di più
https://www.cnn.com/2023/02/24/health/pfizer-rsv-vaccine-guillain-barre/index.html
CNN
—
Two people who received Pfizer’s respiratory syncytial virus (RSV) vaccine during a clinical trial were later diagnosed with Guillain-Barre syndrome, and the US Food and Drug Administration has asked Pfizer to conduct a safety study if the shot is approved, according to agency documents released Friday.
mostra meno
CNN
—
Two people who received Pfizer’s respiratory syncytial virus (RSV) vaccine during a clinical trial were later diagnosed with Guillain-Barre syndrome, and the US Food and Drug Administration has asked Pfizer to conduct a safety study if the shot is approved, according to agency documents released Friday.
Informazioni
| Autore | UniquilbriuM |
| Organizzazione | Flor and Hakeem |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Commenti